Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > New Data Format

<< Previous

Bullboard Posts

Next >>

Comment by CancerSlayeron Apr 27, 2023 4:59pm

168 Views

Post# 35418002

RE:RE:RE:New Data Format

The reported data, plot & KM Curve "does" include the 12 undertreated per my reading. My point was that these 12 should have been dismissed or not be included in the KM analysis...or any other analysis for that matter. The current data on active trial patients (i.e. those who have not been assessed at 450 days, but continue in the trial) point to a durable response that exceeds 30%. All imo.

<< Previous

Bullboard Posts

Next >>

BMO evolves InvestorLine with enhanced tools for options trading